Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulation Therapy for Primary Prevention of Urinary Tract Infections in Patients With Spinal Cord Injury During First Rehabilitation: a Randomized Controlled Pilot Study

NCT04049994 is registered in ClinicalTrials.gov with Swiss Paraplegic Research, Nottwil as lead sponsor.

NCT NCT04049994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulation Therapy for Primary Prevention of Urinary Tract Infections in Patients With Spinal Cord Injury During First Rehabilitation: a Randomized Controlled Pilot Study
Lead sponsor
Swiss Paraplegic Research, Nottwil
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2020
Completion date
October 31, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injuries, urinary tract infections